Opening Presentation: Evaluating the Unmet Clinical Need in the Angiogenesis-Driven Diseases, Neovascular/Wet Age-Related Macular Degeneration (AMD) & Diabetic Macular Edema (DME)

Time: 8:50 am
day: Day One


  • Assessing the treatment burden of existing therapies and the unmet clinical need of anti-VEGF non-responders
  • Increasing the durability of anti-VEGF approaches
  • Novel pharmacological approaches being investigated to improve efficacy and durability compared to the current standard-of-care